MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Classifying carriers of the G2019S mutation in the LRRK2 gene using MRI radiomics analysis

    M. Artzi, A. Thaler, A. Orr Urterger, T. Hendler, M. Sela, A. Mirelman, D. Ben Bashat (Tel Aviv, Israel)

    Objective: To use radiomics approach based on conventional MRI to classify carriers of LRRK2 mutation among non-manifesting first degree relatives of patients with PD. Background:…
  • 2018 International Congress

    Return to automaticity: cortical activity during gait in Parkinson’s disease

    S. Stuart, R. Morris, G. Booth, M. Mancini (Portland, OR, USA)

    Objective: This study investigated pre-frontal cortex (PFC) activation while walking in older adults and people with Parkinson’s disease (PD). We specifically examined 1) PFC activation…
  • 2018 International Congress

    Early cortical signature of development of visual hallucinations in ‘de novo’ Parkinson’s disease

    H. Bejr-kasem, J. Pagonabarraga, S. Martínez-Horta, F. Sampedro, J. Marin-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore, in patients with newly diagnosed Parkinson's disease (PD), grey matter volume (GMV) differences at baseline in those participants who will develop hallucinations…
  • 2018 International Congress

    Combined Neurite Orientation Dispersion and Density Imaging and Myelin Imaging Provide New Insights to White Matter Changes of the Neurocognitive-psychiatric Disorder in Parkinson’s Disease

    C. Andica, K. Kamagata, T. Hatano, A. Saito, Y. Takenaka, T. Ogawa, G. Oyama, Y. Shimo, M. Hori, N. Hattori, S. Aoki (Tokyo, Japan)

    Objective: To identify white matter (WM) changes in PD with neurocognitive-psychiatric symptoms (NPS) using neurite orientation dispersion and density imaging (NODDI) and magnetization transfer saturation…
  • 2018 International Congress

    Beta burst coupling across the motor circuit in patients with Parkinson’s disease

    G. Tinkhauser, F. Torrecillos, Y. Duclos, H. Tan, A. Pogosyan, P. Fischer, R. Carron, M. Welter, C. Karachi, W. Vandenberghe, B. Nuttin, T. Witjas, J. Régis, J. Azulay, A. Eusebio, P. Brown (Oxford, United Kingdom)

    Objective: Here, we test the hypothesis that beta bursts not only involve dynamically elevated local synchronisation but also distributed coupling across circuit nodes, further restricting…
  • 2018 International Congress

    Microstructural Abnormalities in Drug-naïve Parkinson’s Disease with Mild Cognitive Impairment: A Diffusion Tensor Imaging Study

    N. Li, L. Wang, X. Suo, Z. Lu, J. Li, J. Peng, Q. Gong, R. Peng (Chengdu, Sichuan Province, China)

    Objective: The aim of this study was to use MR diffusion tensor imaging to investigate the brain microstructural alterations in newly diagnosed drug-naïve Parkinson’s disease…
  • 2018 International Congress

    Clinical and imaging progression in the PARS cohort: Results from 6 years of observation

    D. Jennings, A. Siderowf, S. Eberly, D. Oakes, M. Stern, K. Marek (New Haven, CT, USA)

    Objective: The goal of the Parkinson Associated Risk Syndrome (PARS) study is to explore the clinical and biomarker trajectory of individuals in the pre-motor phase…
  • 2018 International Congress

    In vivo staging of pathology in REM sleep behaviour disorder

    K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, M. Otto, K. Svendsen, A. Nahimi, M. Stokholm, N. Pavese, C. Beier, D. Brooks, P. Borghammer (Aarhus, Denmark)

    Objective: To study the level of dysfunction in the peripheral and central nervous system in idiopathic REM sleep behaviour disorder (iRBD) patients. Background: α-synuclein (α-syn)…
  • 2018 International Congress

    Absence of the nigrosome-1 area in 3 tesla resonance and its relation with hyperechogenicity of the substantia nigra in patients with Parkinson’s disease

    J.S. Bestoso, M. Pérez Akly, L. Ciancaglini, C. Stefani C, J. Norscini, J. Funes, C. Besada, D. Bauso (Buenos Aires, Argentina)

    Objective: To compare the usefulness of two neuroimaging methods (3TMR and MEcho) to assist in the diagnosis of PD. Background: In patients with Parkinson's disease…
  • 2018 International Congress

    Cholinergic basal forebrain and hippocampal structure influence visuospatial function in Parkinson’s disease

    R. Berlot, S. Brezovar, B. Koritnik, Z. Pirtošek, N. Ray (Ljubljana, Slovenia)

    Objective: To assess relationships between the structural status of the cholinergic basal forebrain (cBF), hippocampus (HPC) and multi-domain cognitive function in Parkinson’s disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 1340
  • 1341
  • 1342
  • 1343
  • 1344
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley